ATE504290T1 - Zusammensetzungen mit neramexan - Google Patents

Zusammensetzungen mit neramexan

Info

Publication number
ATE504290T1
ATE504290T1 AT04810445T AT04810445T ATE504290T1 AT E504290 T1 ATE504290 T1 AT E504290T1 AT 04810445 T AT04810445 T AT 04810445T AT 04810445 T AT04810445 T AT 04810445T AT E504290 T1 ATE504290 T1 AT E504290T1
Authority
AT
Austria
Prior art keywords
neramexan
compositions
Prior art date
Application number
AT04810445T
Other languages
English (en)
Inventor
Mahendra Dedhiya
Shashank Mahashabde
Yan Yang
Anshu Goel
Erhard Seiller
Bernhard Hauptmeier
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34572981&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE504290(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Application granted granted Critical
Publication of ATE504290T1 publication Critical patent/ATE504290T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04810445T 2003-11-05 2004-11-05 Zusammensetzungen mit neramexan ATE504290T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51798103P 2003-11-05 2003-11-05
PCT/US2004/037026 WO2005044228A2 (en) 2003-11-05 2004-11-05 Compositions comprising cyclohexylamines and aminoadamantanes

Publications (1)

Publication Number Publication Date
ATE504290T1 true ATE504290T1 (de) 2011-04-15

Family

ID=34572981

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04810445T ATE504290T1 (de) 2003-11-05 2004-11-05 Zusammensetzungen mit neramexan

Country Status (19)

Country Link
US (4) US20070270500A1 (de)
EP (2) EP1684715B1 (de)
AR (1) AR046314A1 (de)
AT (1) ATE504290T1 (de)
AU (1) AU2004287489B9 (de)
CA (1) CA2543865C (de)
CL (1) CL2008000125A1 (de)
CY (1) CY1111456T1 (de)
DE (1) DE602004032164D1 (de)
DK (1) DK1684715T3 (de)
ES (2) ES2362581T3 (de)
HR (1) HRP20110482T1 (de)
IL (1) IL175623A (de)
PL (1) PL1684715T3 (de)
PT (1) PT1684715E (de)
SI (1) SI1684715T1 (de)
TW (1) TWI350750B (de)
WO (1) WO2005044228A2 (de)
ZA (1) ZA200603561B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060002999A1 (en) 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
EP1765287A2 (de) * 2004-06-17 2007-03-28 Merz Pharma GmbH & Co. KGaA Formulierungen für die sofortige freisetzung oraler memantin-darreichungsformen
US20070060887A1 (en) * 2005-08-22 2007-03-15 Marsh David A Ophthalmic injector
TW200916091A (en) * 2007-06-08 2009-04-16 Merz Pharma Gmbh & Amp Co Kgaa Neramexane for the treatment of nystagmus
TW200927087A (en) 2007-09-12 2009-07-01 Merz Pharma Gmbh & Co Kgaa Titration package for 1-amino-alkylcyclohexanes
TW201006463A (en) * 2008-06-26 2010-02-16 Merz Pharma Gmbh & Co Kgaa Pharmaceutical compositions comprising aminocyclohexane derivatives
EP2373304B1 (de) 2008-12-19 2014-07-30 Merz Pharma GmbH & Co. KGaA Neramexane zur Behandlung von Mastzellen-vermittelten Erkrankungen
TWI432188B (zh) 2008-12-19 2014-04-01 Merz Pharma Gmbh & Co Kgaa 供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類
WO2011157449A1 (en) 2010-06-18 2011-12-22 Merz Pharma Gmbh & Co. Kgaa Gel formulations for the topical use of 1-amino-alkylcyclohexane derivatives

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH603545A5 (de) 1972-04-20 1978-08-31 Merz & Co
DE2856393C2 (de) 1978-12-27 1983-04-28 Merz + Co GmbH & Co, 6000 Frankfurt Arzneimittel zur Behandlung von Morbus Parkinson
US5506231A (en) 1989-03-31 1996-04-09 The Children's Medical Center Corporation Treatment of aids dementia, myelopathy and blindness
US5334618A (en) 1991-04-04 1994-08-02 The Children's Medical Center Corporation Method of preventing NMDA receptor-mediated neuronal damage
DE10299048I2 (de) 1989-04-14 2006-07-13 Merz Pharma Gmbh & Co Kgaa Verwendung von Adamantan-Derivaten zur Pr{vention und Behandlung der cerebralen Isch{mie
US5614560A (en) 1991-04-04 1997-03-25 Children's Medical Center Corporation Method of preventing NMDA receptor-mediated neuronal damage
US5455279A (en) 1991-04-19 1995-10-03 The Children's Medical Center Corporation Regimen method of mediating neuronal damage using nitroglycerine
WO1992018112A1 (en) 1991-04-19 1992-10-29 The Children's Medical Center Corporation Method of preventing nmda receptor complex-mediated neuronal damage
US6071966A (en) * 1997-06-30 2000-06-06 Merz + Co. Gmbh & Co. 1-amino-alkylcyclohexane NMDA receptor antagonists
GEP20032995B (en) 1997-06-30 2003-06-25 Merz & Co Gmbh & Co 1-Amino-Alkylcyclohexane NMDA Receptor Antagonists
SE9901077D0 (sv) 1999-03-23 1999-03-23 Astra Ab Novel use
US6444702B1 (en) 2000-02-22 2002-09-03 Neuromolecular, Inc. Aminoadamantane derivatives as therapeutic agents
TW593223B (en) * 2000-06-20 2004-06-21 Merz Pharma Gmbh & Co Kgaa 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
MXPA03005130A (es) * 2000-12-07 2004-12-06 Neuromolecular Inc Metodos para tratar trastornos neurosiquiatricos con antagonistas del receptor del nmda.
US6828462B2 (en) * 2001-11-07 2004-12-07 Merz Pharma Gmbh & Co. Kgaa Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
EP1523309A2 (de) * 2002-07-19 2005-04-20 Khalid Iqbal Nmda rezeptor antagonisten und deren verwendung in der hemmung abnormaler hyperphosphorilierung von microtubulärem protein tau
CN1794981A (zh) * 2003-05-27 2006-06-28 森林实验室公司 治疗抑郁症和其它情绪障碍的nmda受体拮抗剂和选择性5－羟色胺重摄取抑制剂的组合

Also Published As

Publication number Publication date
DK1684715T3 (da) 2011-07-11
WO2005044228A3 (en) 2006-06-22
PT1684715E (pt) 2011-05-02
PL1684715T3 (pl) 2011-09-30
HRP20110482T1 (hr) 2011-07-31
ES2362581T3 (es) 2011-07-07
EP1684715A2 (de) 2006-08-02
US20120238631A1 (en) 2012-09-20
AU2004287489B9 (en) 2008-10-09
IL175623A (en) 2012-10-31
ES2507500T3 (es) 2014-10-15
ZA200603561B (en) 2007-07-25
US20070270500A1 (en) 2007-11-22
AU2004287489B2 (en) 2008-08-28
AU2004287489A1 (en) 2005-05-19
EP2289489A2 (de) 2011-03-02
CA2543865A1 (en) 2005-05-19
CA2543865C (en) 2012-09-04
EP2289489A3 (de) 2012-06-06
TWI350750B (en) 2011-10-21
EP2289489B1 (de) 2014-07-16
EP1684715B1 (de) 2011-04-06
CY1111456T1 (el) 2015-08-05
WO2005044228A2 (en) 2005-05-19
US20140350114A1 (en) 2014-11-27
CL2008000125A1 (es) 2008-03-14
AR046314A1 (es) 2005-11-30
DE602004032164D1 (de) 2011-05-19
US20100035995A1 (en) 2010-02-11
SI1684715T1 (sl) 2011-07-29
TW200526195A (en) 2005-08-16

Similar Documents

Publication Publication Date Title
FR2862654B1 (fr) Composition amylacee filmogene
ATE363383T1 (de) Schlingenware
DE10393374D2 (de) Zusammensetzung
DE502004011333D1 (de) Polyalkenamine mit verbesserten anwendungseigenschaften
ATE491774T2 (de) Benzinzusammensetzung
FR2863890B1 (fr) Composition immunostimulante
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
DE602004004388D1 (de) Verdickbare zusammensetzungen
DK1704213T3 (da) Petroleumpræparat
DE112004000620D2 (de) Struktoguss
SE0500163L (sv) Sammansättning
ATA662003A (de) Trink-mundstück
ATE504290T1 (de) Zusammensetzungen mit neramexan
ATE446959T1 (de) Chromenonindole
ATE356555T1 (de) Nahrungsmittelzusammensetzung
DK1633719T3 (da) Substituerede spirobenzazepiner
DE602004000590T8 (de) Harzzusammensetzung
DE10394329D2 (de) Mäanderstent
DE10355350A8 (de) Elektromodul
ATE365529T1 (de) Schweisshemmende zusammensetzungen
ATE406350T1 (de) Prolinylarylacetamide
DE112004002110D2 (de) Behälter-Deckel-Kombination
DE10329218B4 (de) Hotflue
DE502004006442D1 (de) Bauelement
DE10316511B4 (de) Teigportionierer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1684715

Country of ref document: EP